The Patriot Pony Bonus Section
Monday, December 20, 2021
OSHA delays compliance and enforcement dates for reinstated vaccine or test mandate By Resist The Mainstream Staff EDITOR’S NOTE—This section is reserved as an editorial and may not necessarily reflect the policy of this publication.
In 2002, Pfizer agreed to pay $49 million to settle allegations that the pharmaceutical company defrauded the federal government and 40 states by overcharging its cholesterol drug Lipitor. https://web.archive.org/ web/20210223140005/ https:// www.nytimes.com/2002/1 0/29/business/pfizer-topay-49-million-in-fraudcase.html ▪️In 2004, Pfizer agreed to plead guilty to two felonies and paid $430 million in fines to settle charges that it fraudulently promoted the drug Neurontin for unauthorized use. ▪️2008: "Experts concluded that Pfizer manipulated research" by delaying the publication of negative studies, distorted negative data to present them in a more positive light, and controlled the flow of clinical trial data. https://web.archive.org/ web/20210520230550/ https:// www.nytimes.com/2008/1 0/08/health/ research/08drug.html ▪️In 2009, Pfizer paid $750 million to settle 35,000 complaints that its drug Rezulin caused 63 deaths and thousands of cases of liver failure. As a result, the drug Rezulin was completely withdrawn. https://www.latimes.com/ archives/la-xpm-2001-dec22-mn-17267-story.html ▪️In 2012, the Securities and Exchange Commission accused Pfizer Inc. of violating the Corrupt Practices Abroad Act (FCPA WIKI) when its subsidiaries bribed doctors and other medical professionals from governments.
***** As crime in the US continues to rise, California residents have decided to leave their cars parked with the trunk open in a desperate attempt to keep robbers from breaking windows and damaging their property. In addition to violent and other serious crimes, car break-ins are out of control (Continued on page 20)
The Occupational Health and Safety Administration (OSHA) on Saturday announced a six-day grace period beyond the Jan. 4 deadline for compliance with its COVID-19 vaccine mandate for private employers, saying that it would not issue citations to give employers more time to adjust. OSHA said in a Dec. 18 statement that it would not be issuing citations to businesses for noncompliance with any requirements of the Biden administration’s COVID-19 vaccine-or-test mandate for private companies employing 100 or more people until Jan. 10. It will also not issue any citations for noncompliance with the mandate’s testing requirements until Feb. 9. The announcement comes a day after the U.S. Court of Appeals for the 6th District in Cincinnati ruled that the private employer mandate could proceed, reversing a previous court decision that blocked the measure in the face of legal challenges by 27 Republican-led states, conservative groups, business associations, and some individual firms. “OSHA is gratified the U.S. Court of Appeals for the Sixth Circuit dissolved the Fifth Circuit’s stay of the Vaccination and Testing Emergency Temporary Standard. OSHA can now once again implement this vital workplace health standard, which will protect the health of workers by mitigating the spread of the unprecedented virus in the workplace,” the agency said.
The agency said it was providing the grace period to “account for any uncertainty created by the stay” and that it would “work closely with the regulated community to provide compliance assistance.” The OSHA rule applies to some 84 million U.S. workers who would be required to be fully vaccinated against COVID-19 or wear masks and be tested weekly. The rule threatens fines of up to $13,600 per violation, with a potential additional $13,600 fine for each day that an employer does not abate the violation. For willful, or serious, violations OSHA could issue a fine of up to $136,000. The 6th District’s ruling to dissolve the stay on the OSHA rule was criticized by Arkansas Attorney General Leslie Rutledge, who said in a statement that she would move to ask the U.S. Supreme Court to block it. “The Sixth Circuit’s decision is extremely disappointing for Arkansans because it will force them to get the shot or lose their jobs,” she said. South Carolina Attorney General Alan Wilson, who chairs the Republican Attorneys General Association, also expressed disappointment in the ruling. “We are confident the mandate can be stopped,” he wrote on Twitter, adding: “We will go immediately to the Supreme Court—the highest court in the land—to fight this unconstitutional and illegal mandate. The law must be followed and federal abuse of power stopped.”
Subscribe for free
$0.00—online only
World awakening and silent war FDA Strengthens Warning Over Severe Condition Linked to Johnson & Johnson’s COVID -19 Vaccine By Resist the Mainstream Staff U.S. drug regulators this week formally strengthened a warning to Americans regarding a severe condition linked to Johnson & Johnson’s COVID-19 vaccine. Blood clots and low blood platelet levels, known as thrombosis with thrombocytopenia syndrome (TTS), are now listed as a contradiction, or a medical reason for somebody not to get the shot. “Do not administer” the vaccine to individuals with a history of the set of conditions following the vaccine or any other adenovirus-vectored COVID19 vaccine, the Food and Drug Administration (FDA) says in an updated fact sheet (pdf) for health care providers administering vaccines. TTS has been reported in “a wide range of individuals 18 years and older” since administration of the Johnson & Johnson (J&J) vaccine began earlier this year, regulators say. The highest reporting rate, approximately 1 case per 100,000 doses administered, has occurred in women aged 30 to 49. About 15 percent of the TTS cases have been fatal. “Currently available
evidence supports a causal relationship between TTS and the Janssen COVID-19 Vaccine,” the FDA says in its updated fact sheets. Janssen is a subsidiary of J&J. J&J did not respond to a request for comment. In the spring, U.S. health officials recommended a nationwide pause in administration of the vaccine due to TTS cases appearing among people who had gotten it. The pause was lifted in April. The FDA and Centers for Disease Control and Prevention (CDC) said at the time that officials were confident the vaccine was safe and effective in preventing COVID19. The FDA said that the available data showed the known and potential benefits outweigh its known and potential risks. Paul Stoffels, J&J’s chief scientific officer, said when the pause was lifted that the company would work with health authorities worldwide “to educate health care professionals and the public to ensure this very rare event can be identified early and treated effectively.” More recently, a Mayo Clinic study found J&J vaccine recipients had a higher risk of blood clots. Three COVID-19 vaccines are available for use in the United States. J&J’s is by far
the least used. Just 17.2 million doses have been administered as of Dec. 15, compared to 185.8 million doses of Moderna’s vaccine and 283 million doses of the PfizerBioNTech vaccine. A Mayo Clinic study in November found J&J vaccine recipients had a higher risk of blood clots when compared to recipients of the other two shots. Currently, there are no restrictions in place on administration of the J&J jab. The two contraindications, TTS and severe allergic reaction, typically only apply once a person has suffered an adverse event. The CDC’s vaccine advisory panel is meeting Thursday to hear presentations from the CDC on J&J’s vaccine. This is an excerpt from The Epoch Times. Sweden Sees Increase In Microchips Inserted In Hands for COVID-19 Passports ***** By Prof Michel Chossudovsky Global Research, December 14, 2021 The World Economic Forum is simulating a global cyberattack that could lead to a "great reset." "The World Economic Forum (WEF) which represents the Western financial elites, played a key role in the launching of the
(Continued on page 20)
